ArticleJournal of nanobiotechnology2021

Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small-molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids.

Ezgi Oner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.